Glaukos
Valerie Smith has an extensive background in clinical research and pharmaceuticals, having held various leadership roles in companies such as Glaukos Corporation, Graybug Vision, Inc., Amgen, Onyx Pharmaceuticals, Shire Pharmaceuticals, SARcode Bioscience, Inc., SARcode Corporation, Inc., Genentech, BioMarin, and VaxGen. Valerie currently serves as the Vice President Clinical Research at Glaukos Corporation, where Valerie brings a wealth of experience in global clinical development operations. Valerie holds a Master of Business Administration degree from Kennesaw State University.
This person is not in any offices
Glaukos
3 followers
At Glaukos, their focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.